Elotuzumab monoclonal antibody drug. Targets SLAMF7 (CD319) and is used in the treatment of multiple myeloma. Generic name and stylized antibody.

---

Size: 9000px × 3474px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: antibody, biological, biosimilar, biotech, biotechnology, cancer, cd319, disease, drug, elotuzumab, immunoglobulin, immunology, infusion, injection, inn, mab, monoclonal, multiple, myeloma, nomenclature, oncology, peptide, protein, slamf7